{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:10:57Z","timestamp":1788999057257,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cellulitis is an infection most commonly caused by bacteria and successfully treated with antibiotics. However, certain patient populations, especially the immunocompromised, are at risk for fungal cellulitis, which can be misidentified as bacterial cellulitis and contribute to significant morbidity and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentations<\/jats:title>\n                <jats:p>We describe three cases of opportunistic fungal cellulitis in immunosuppressed patients that were initially mistaken for bacterial infections refractory to antibiotic therapy. However, atypical features of cellulitis ultimately prompted further diagnostics to identify fungal cellulitis and allow initiation of appropriate antifungals. We discuss: (1) a 52-year-old male immunosuppressed hematopoietic cell transplant recipient with <jats:italic>Fusarium solani<\/jats:italic> cellulitis on his right lower extremity that was treated with amphotericin B and voriconazole with full resolution of the cellulitis; (2) a 70-year-old male lung transplant recipient with <jats:italic>Fusarium solani<\/jats:italic> cellulitis on his left lower extremity that ultimately progressed despite antifungals; and (3) a 68-year-old male with a history of kidney transplantation with suspected <jats:italic>Purpureocillium lilacinum<\/jats:italic> cellulitis on his left lower extremity ultimately treated with posaconazole with resolution of the skin lesions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p><jats:italic>Fusarium solani<\/jats:italic> and <jats:italic>Purpureocillium lilacinum<\/jats:italic> are important pathogens causing opportunistic fungal cellulitis. These cases remind providers to be vigilant for fungal cellulitis when skin and soft tissue infection does not adequately respond to antibiotics and atypical features of cellulitis are present.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07365-8","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T12:11:49Z","timestamp":1651752709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic and therapeutic challenges of treating opportunistic fungal cellulitis: a case series"],"prefix":"10.1186","volume":"22","author":[{"given":"Jed","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8986-5419","authenticated-orcid":false,"given":"Mary M.","family":"Czech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Balijepally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Wes","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,5]]},"reference":[{"key":"7365_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.4065\/82.7.817","volume":"82","author":"DR McNamara","year":"2007","unstructured":"McNamara DR, Tleyjeh IM, Berbari EF, Lahr BD, Martinez JW, Mirzoyev SA, et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted county,\u00a0Minnesota. Mayo Clin Proc. 2007;82:817\u201321.","journal-title":"Mayo Clin Proc."},{"key":"7365_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","volume":"89","author":"A Jeng","year":"2010","unstructured":"Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine. 2010;89:217\u201326.","journal-title":"Medicine"},{"key":"7365_CR3","doi-asserted-by":"publisher","first-page":"e005101","DOI":"10.1099\/jmmcr.0.005101","volume":"4","author":"D Sotello","year":"2017","unstructured":"Sotello D, Cappel M, Huff T, Meza D, Alvarez S, Libertin CR. Cutaneous fungal infection in an immunocompromised host. JMM Case Rep. 2017;4:e005101.","journal-title":"JMM Case Rep"},{"key":"7365_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1534734607313879","volume":"7","author":"A Rekha","year":"2008","unstructured":"Rekha A, Kindo AJ, Ravi A. Fusarium solani in the post-transplant patient: an unusual fungus. Int J Low Extrem Wounds. 2008;7:38\u201340.","journal-title":"Int J Low Extrem Wounds"},{"key":"7365_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MD.0000000000000008","volume":"92","author":"M Muhammed","year":"2013","unstructured":"Muhammed M, Anagnostou T, Desalermos A, Kourkoumpetis TK, Carneiro HA, Glavis-Bloom J, et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine. 2013;92:305\u201316.","journal-title":"Medicine"},{"key":"7365_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3855\/jidc.12235","volume":"14","author":"MA Salazar-Gonz\u00e1lez","year":"2020","unstructured":"Salazar-Gonz\u00e1lez MA, Violante-Cumpa JR, Alfaro-Rivera CG, Villanueva-Lozano H, Trevi\u00f1o-Rangel R, de Gonz\u00e1lez J. Purpureocillium lilacinum as unusual cause of pulmonary infection in immunocompromised hosts. J Infect Dev Ctries. 2020;14:415\u20139.","journal-title":"J Infect Dev Ctries"},{"key":"7365_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2567.2007.02719.x","volume":"123","author":"GE Kaiko","year":"2008","unstructured":"Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology. 2008;123:326\u201338.","journal-title":"Immunology"},{"key":"7365_CR8","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/mi.2013.107","volume":"7","author":"P Bacher","year":"2014","unstructured":"Bacher P, Kniemeyer O, Sch\u00f6nbrunn A, Sawitzki B, Assenmacher M, Rietschel E, et al. Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. Mucosal Immunol. 2014;7:916\u201328.","journal-title":"Mucosal Immunol"},{"key":"7365_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1574-6968.2011.02322.x","volume":"321","author":"J Luangsa-Ard","year":"2011","unstructured":"Luangsa-Ard J, Houbraken J, van Doorn T, Hong S-B, Borman AM, Hywel-Jones NL, et al. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett. 2011;321:141\u20139.","journal-title":"FEMS Microbiol Lett"},{"key":"7365_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fcimb.2019.00257","volume":"9","author":"P Li","year":"2019","unstructured":"Li P, Bhattacharjee P, Wang S, Zhang L, Ahmed I, Guo L. Mycoviruses in species: an update. Front Cell Infect Microbiol. 2019;9:257.","journal-title":"Front Cell Infect Microbiol"},{"key":"7365_CR11","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3389\/fmicb.2017.01617","volume":"8","author":"DCM de Sequeira","year":"2017","unstructured":"de Sequeira DCM, Menezes RC, Oliveira MME, Antas PRZ, De Luca PM, de Oliveira-Ferreira J, et al. Experimental Hyalohyphomycosis by outcome of the Infection in C57BL\/6 murine models. Front Microbiol. 2017;8:1617.","journal-title":"Front Microbiol"},{"key":"7365_CR12","doi-asserted-by":"publisher","unstructured":"Trinh SA, Angarone MP. Purpureocillium lilacinum tattoo-related skin infection in a kidney transplant recipient. Transpl Infect Dis. 2017;19. https:\/\/doi.org\/10.1111\/tid.12689.","DOI":"10.1111\/tid.12689"},{"key":"7365_CR13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2340\/00015555-3320","volume":"99","author":"W-Y Chen","year":"2019","unstructured":"Chen W-Y, Lin S-R, Hung S-J. Successful treatment of recurrent cutaneous Purpureocillium lilacinum (Paecilomyces lilacinus) Infection with Posaconazole and Surgical Debridement. Acta Derm Venereol. 2019;99:1313\u20134.","journal-title":"Acta Derm Venereol"},{"key":"7365_CR14","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1128\/JCM.44.5.1869-1872.2006","volume":"44","author":"C Matkoski","year":"2006","unstructured":"Matkoski C, Sharp SE, Kiska DL. Evaluation of the Q score and Q234 systems for cost-effective and clinically relevant interpretation of wound cultures. J Clin Microbiol. 2006;44:1869\u201372.","journal-title":"J Clin Microbiol"},{"key":"7365_CR15","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1128\/AAC.00538-08","volume":"52","author":"MV Castelli","year":"2008","unstructured":"Castelli MV, Alastruey-Izquierdo A, Cuesta I, Monzon A, Mellado E, Rodriguez-Tudela JL, et al. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob Agents Chemother. 2008;52:2926\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"7365_CR16","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1469-0691.2006.01481.x","volume":"12","author":"FJ Pastor","year":"2006","unstructured":"Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect. 2006;12:948\u201360.","journal-title":"Clin Microbiol Infect"},{"key":"7365_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/13693780500088416","volume":"43","author":"GM Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez GM, Fothergill AW, Sutton DA, Rinaldi MG, Loebenberg D. In vitroactivities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med Mycol. 2005;43:281\u20134. https:\/\/doi.org\/10.1080\/13693780500088416.","journal-title":"Med Mycol"},{"key":"7365_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000080853","volume":"209","author":"J-C Roujeau","year":"2004","unstructured":"Roujeau J-C, Sigurgeirsson B, Korting H-C, Kerl H, Paul C. Chronic dermatomycoses of the foot as risk factors for acute bacterial cellulitis of the leg: a case\u2013control study. Dermatology. 2004;209:301\u20137.","journal-title":"Dermatology"},{"key":"7365_CR19","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1086\/497127","volume":"41","author":"S Bj\u00f6rnsd\u00f3ttir","year":"2005","unstructured":"Bj\u00f6rnsd\u00f3ttir S, Gottfredsson M, Th\u00f3risd\u00f3ttir AS, Gunnarsson GB, R\u00edkardsd\u00f3ttir H, Kristj\u00e1nsson M, et al. Risk factors for acute cellulitis of the lower limb: a prospective case\u2013control study. Clin Infect Dis. 2005;41:1416\u201322.","journal-title":"Clin Infect Dis"},{"key":"7365_CR20","first-page":"1","volume":"2014","author":"D Zhou","year":"2014","unstructured":"Zhou D, Zhang X, Du Y, Dong S, Xu Z, Yan L. Insights into the synergistic effect of fungi and bacteria for reactive red decolorization. J Spectrosc. 2014;2014:1\u20134.","journal-title":"J Spectrosc"},{"key":"7365_CR21","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.3201\/eid1910.120847","volume":"19","author":"M Nucci","year":"2013","unstructured":"Nucci M, Varon AG, Garnica M, et al. Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis. 2013;19:1567\u201372. https:\/\/doi.org\/10.3201\/eid1910.120847.","journal-title":"Emerg Infect Dis"},{"key":"7365_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/00128071-200607010-00004","volume":"7","author":"SR Mays","year":"2006","unstructured":"Mays SR, Bogle MA, Bodey GP. Cutaneous fungal infections in the oncology patient: recognition and management. Am J Clin Dermatol. 2006;7:31\u201343.","journal-title":"Am J Clin Dermatol"},{"key":"7365_CR23","doi-asserted-by":"publisher","first-page":"e1018","DOI":"10.1097\/MD.0000000000001018","volume":"94","author":"C Bernardeschi","year":"2015","unstructured":"Bernardeschi C, Foulet F, Ingen-Housz-Oro S, Ortonne N, Sitbon K, Quereux G, et al. French Mycosis Study Group. Cutaneous invasive Aspergillosis: retrospective multicenter study of the french invasive-aspergillosis registry and literature review. Med (Baltim). 2015;94:e1018. https:\/\/doi.org\/10.1097\/MD.0000000000001018.","journal-title":"Med (Baltim)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07365-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07365-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T12:14:56Z","timestamp":1651752896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07365-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7365"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07365-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,5]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent from one patient was obtained to disclose clinical details and identifying images to participate in the case report. Written consent from next of kin was obtained to disclose clinical details and identifying imaging to participate in the case report for the other two patients, who were deceased at the time of manuscript preparation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have financial or non-financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}